Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: A single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers

MLA

Sang-Goo Shin, et al. “Pharmacokinetic Comparison of a New Glimepiride 1-Mg + Metformin 500-Mg Combination Tablet Formulation and a Glimepiride 2-Mg + Metformin 500-Mg Combination Tablet Formulation: A Single-Dose, Randomized, Open-Label, Two-Period, Two-Way Crossover Study in Healthy, Fasting Korean Male Volunteers.” Clinical Therapeutics, vol. 31, Nov. 2009, pp. 2755–64. EBSCOhost, https://doi.org/10.1016/j.clinthera.2009.11.001.

APA

Sang-Goo Shin, In-Jin Jang, Kyung Sang Yu, Kwang-Hee Shin, Kyoung Soo Lim, Jung-Ryul Kim, Kyu-Pyo Kim, Joo Youn Cho, JaeWoo Kim, & Bo-Hyung Kim. (2009). Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: A single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers. Clinical Therapeutics, 31, 2755–2764. https://doi.org/10.1016/j.clinthera.2009.11.001

Chicago

Sang-Goo Shin, In-Jin Jang, Kyung Sang Yu, Kwang-Hee Shin, Kyoung Soo Lim, Jung-Ryul Kim, Kyu-Pyo Kim, Joo Youn Cho, JaeWoo Kim, and Bo-Hyung Kim. 2009. “Pharmacokinetic Comparison of a New Glimepiride 1-Mg + Metformin 500-Mg Combination Tablet Formulation and a Glimepiride 2-Mg + Metformin 500-Mg Combination Tablet Formulation: A Single-Dose, Randomized, Open-Label, Two-Period, Two-Way Crossover Study in Healthy, Fasting Korean Male Volunteers.” Clinical Therapeutics 31 (November): 2755–64. doi:10.1016/j.clinthera.2009.11.001.